Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Sposto

Showing results (81-90 of 180) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 studyMitchell S Cairo, Richard Sposto, Mary Gerrard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Late congestive heart failure after hematopoietic cell transplantationSaro H Armenian, Can-Lan Sun, Liton Francisco, et al.
Pediatric Blood & Cancer|July 5, 2007
Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factorsStergios Zacharoulis, Lingyun Ji, Ian F Pollack, et al.
Pediatric Blood & Cancer|June 29, 2010
Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortiumYoav Messinger, Paul Gaynon, Elizabeth Raetz, et al.
Blood|November 30, 2006
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patientsCatherine Patte, Anne Auperin, Mary Gerrard, et al.
Radiation Research|January 27, 2026
Cataracts in Atomic-bomb Survivors More than 70 Years after Radiation ExposureAyumi Hida, Kozue Ohno, Mariko Yamamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group reportMark A Lones, Sherrie L Perkins, Richard Sposto, et al.
Gynecologic Oncology|October 25, 2016
Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin responseKatherine E Tierney, Lingyun Ji, Shannon S Dralla, et al.
Blood|December 2, 2006
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescentsMitchell S Cairo, Mary Gerrard, Richard Sposto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology GroupSuzanne L Wolden, Lu Chen, Kara M Kelly, et al.
Pageof 18

Showing results (81-90 of 180) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 studyMitchell S Cairo, Richard Sposto, Mary Gerrard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Late congestive heart failure after hematopoietic cell transplantationSaro H Armenian, Can-Lan Sun, Liton Francisco, et al.
Pediatric Blood & Cancer|July 5, 2007
Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factorsStergios Zacharoulis, Lingyun Ji, Ian F Pollack, et al.
Pediatric Blood & Cancer|June 29, 2010
Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortiumYoav Messinger, Paul Gaynon, Elizabeth Raetz, et al.
Blood|November 30, 2006
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patientsCatherine Patte, Anne Auperin, Mary Gerrard, et al.
Radiation Research|January 27, 2026
Cataracts in Atomic-bomb Survivors More than 70 Years after Radiation ExposureAyumi Hida, Kozue Ohno, Mariko Yamamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group reportMark A Lones, Sherrie L Perkins, Richard Sposto, et al.
Gynecologic Oncology|October 25, 2016
Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin responseKatherine E Tierney, Lingyun Ji, Shannon S Dralla, et al.
Blood|December 2, 2006
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescentsMitchell S Cairo, Mary Gerrard, Richard Sposto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology GroupSuzanne L Wolden, Lu Chen, Kara M Kelly, et al.
Pageof 18